Pardeep Nijhawan - 26 Feb 2026 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan
Issuer symbol: EDSA
Transactions as of: 26 Feb 2026
Net transactions value: +$99,176
Form type: 4
Filing time: 02 Mar 2026, 17:05:59 UTC
Previous filing: 02 Mar 2026
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nijhawan Pardeep	Chief Executive Officer, Director, 10%+ Owner	C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA	/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan	02 Mar 2026	0001777962

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDSA	Common Shares	Purchase	$32,480	+20,571	+3.5%	$1.58	615,797	26 Feb 2026	Direct	F1
transaction	EDSA	Common Shares	Award	$0	+10,016	+1.6%	$0.000000	625,813	02 Mar 2026	Direct	F2
transaction	EDSA	Common Shares	Purchase	$66,696	+30,000	+8.8%	$2.22	371,702	27 Feb 2026	Held by Pardeep Nijhawan Medicine Professional Corporation	F3, F4
holding	EDSA	Common Shares						32,609	26 Feb 2026	Held by The New Nijhawan Family Trust 2015	F4
holding	EDSA	Common Shares						32,013	26 Feb 2026	Held by The Digestive Health Clinic Inc.	F5
holding	EDSA	Common Shares						53,104	26 Feb 2026	Held by 1968160 Ontario Inc.	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.58 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
F3	The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.22 to $2.2295 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4	Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F5	Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.